Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 57 (6) , 847-861
- https://doi.org/10.1016/0049-3848(90)90152-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of leupeptin on platelet aggregation, fibrin formation and amidolysis induced by thrombinThrombosis Research, 1987
- Influence of a calcium dependent protease inhibitor on platelet activation and secretionThrombosis Research, 1987
- The Ca2+-activated protease (calpain) modulates Ca2+/calmodulin dependent activity of smooth muscle myosin light chain kinaseBiochemical and Biophysical Research Communications, 1987
- The Metabolism of Phosphoinositide-Derived Messenger MoleculesScience, 1986
- Thrombin and Trypsin Activate Phospholipase C in Human Platelets via a Proteolytic-Mediated PathwaySeminars in Thrombosis and Hemostasis, 1986
- Sustained proteolysis is required for human platelet activation by thrombinThrombosis Research, 1986
- Demonstration of a relationship between talin and P235, a major substrate of the calcium‐dependent protease in plateletsJournal of Cellular Biochemistry, 1986
- Leupeptin selectively inhibits human platelet responses induced by thrombin and trypsin; a role for proteolytic activation of phospholipase CBiochemical and Biophysical Research Communications, 1985
- The role of protein kinase C in cell surface signal transduction and tumour promotionNature, 1984
- Reaction of Calcium-Activated Neutral Protease (CANP) with an Epoxysuccinyl Derivative (E64c) and Iodoacetic Acid1The Journal of Biochemistry, 1983